Shares of Check Cap Ltd (NASDAQ:CHEK) shot up 8% during mid-day trading on Monday . The stock traded as high as $2.04 and last traded at $2.02, with a volume of 57,736 shares traded. The stock had previously closed at $1.87.

Several research firms have issued reports on CHEK. Chardan Capital dropped their price target on shares of Check Cap from $6.00 to $4.00 and set a “buy” rating on the stock in a research report on Friday, May 20th. Maxim Group reaffirmed a “buy” rating on shares of Check Cap in a research report on Thursday, May 19th. Finally, Zacks Investment Research raised shares of Check Cap from a “hold” rating to a “buy” rating and set a $1.50 price target on the stock in a research report on Tuesday, June 14th.

The firm’s 50-day moving average is $1.69 and its 200 day moving average is $2.22. The company’s market cap is $24.75 million.

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.